Crypto News

2 hours ago

Kodiak Sciences (KOD) Stock Surges as Zenkuda Eye Treatment Achieves Phase 3 Success

Stocks

Kodiak Sciences (KOD) stock jumped after Zenkuda met Phase 3 trial goals for diabetic retinopathy, with 62.5% of patients showing significant improvement.

The post Kodiak Sciences (KOD) Stock Surges as Zenkuda Eye Treatment Achieves Phase 3 Success appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$ADA$ARB$BITF$BLSH$BMNR$BONK$CLAW Token Scam$DBKSF$ENA$LUXFF$MATH$MTT token$NIGHT$PUMP$RAY$S$SEA$SOL$SPACE token$SPTZ

Latest News